Promentis Pharmaceuticals, Inc.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Promentis Pharmaceuticals, Inc.
First quarter VC investments in biopharma set high expectations for the second quarter; Acorda cuts jobs after patent litigation defeat, plus other strategic realignments; no new US IPOs, but Europe has three; and notable follow-on offerings.
Recent executive-level company changes and promotions in the biopharma, medical device, and diagnostics industries.
Recent executive-level hires and director appointments at venture capital firms and biopharma and medtech start-ups.
Brief profiles of these recently formed companies: Garnet BioTherapeutics, Medimetriks Pharmaceuticals, OrthAlign and Promentis Pharmaceuticals.